Shi ST, Herlihy KJ, Graham JP, Fuhrman SA, Doan C, Parge H, Hickey M, Gao J, Yu X, Chau F, Gonzalez . In vitro resistance study of AG-021541, a novel nonnucleoside inhibitor of the hepatitis C virus RNA. Antimicrob Agents Chemother . 2008. 52(2). 675-683. Find at Google Scholar.
Cooper C, Lawitz EJ, Ghali P, Rodriguez-Torres M, Anderson FH, Lee SS, Bedard J, Chauret N, Thibert . Evaluation of VCH-759 monotherapy in hepatitis C infection. . J. Hepatol. . 2009. 51. 39-46. Find at Google Scholar.
Bartels DJ, Sullivan JC, Zhang EZ, Tigges AM, Dorrian JL, De Meyer S, Takemoto D, Dondero E, Kwong A. Hepatitis C virus variants with decreased sensitivity to direct-acting antivirals (DAAs) were rarely. J Virol. . 2013. 87(3). 1544-1553. Find at Google Scholar.
Bartels D, Jiang M, Zhang E, Tigges A, Sullivan J, Dorrian J, Spanks J, Ardzinski A, Nicolas O, Beda. Characterization of HCV variants in genotype 1 patients administered VX-222, a non-nucleoside polyme. 5th International Workshop of Hepatitis C Res. 2010. . . Find at Google Scholar.